T5	Exp 210 247	the 85-kDa cytosolic phospholipase A2
T6	Exp 325 330	which
T7	Exp 249 260	This enzyme
T8	Exp 394 415	These lipid mediators
T9	Exp 586 588	We
T10	Exp 611 615	that
T11	Exp 884 889	which
T12	Exp 840 866	the subcellular mechanisms
T13	Exp 828 838	this study
T14	Exp 945 947	We
T15	Exp 959 963	they
T16	Exp 954 958	that
T17	Exp 972 1025	the initial interleukin-1beta mRNA transcription rate
T18	Exp 1358 1369	the cytosol
T19	Exp 1272 1296	this therapeutic potency
R3	Coref Anaphora:T6 Antecedent:T20
R4	Coref Anaphora:T15 Antecedent:T12
T1	Protein 690 707	interleukin-1beta
T2	Protein 984 1001	interleukin-1beta
T3	Protein 1063 1085	inhibitor-kappaB alpha
T4	Protein 1389 1406	interleukin-1beta
T20	Exp 315 324	membranes
